Jeffrey Tepper, PhD, DABT, DSP
Inhalation Toxicology Consultant
Toxicology Drug Development Consultant
  • More than 35 years’ experience, with over ten years’ as a preclinical research and development  consultant
  • Board certification in toxicology and safety pharmacology
  • Successful track record of transitioning early drug concepts from animal pharmacology through GLP  toxicology and into clinical studies
  • Skills honed as a Senior Scientist at Genentech, Director of Pharmacology at Bayer Biotechnology,  VP of Pharmacology/Toxicology at Catalyst Biosciences and as a Co-Founder and Senior Director Pharmacology/Toxicology of Aerovance Inc., a respiratory-focused biotech company
  • Nonclinical drug development• Inhalation toxicology and respiratory pharmacology
  • Inflammatory, cardiovascular, gastrointestinal, ophthalmology and arthropathy indications• Inhalation, intranasal, intra-articular and intravitreal administration
  • Recombinant and engineered proteins, oligonucleotides, antibodies, peptides, small molecules,  PEGylated molecules and drug-device combinations